Chronic NK-cell lymphocytosis is a long-lasting blood condition where natural killer (NK) white blood cells are persistently higher than usual. Many people with chronic NK-cell lymphocytosis have no symptoms, but some notice fatigue, night sweats, or frequent infections. It is usually found in adults during routine blood tests and often stays stable for years. Most people do well and mortality is low, though monitoring is important. Treatment is often observation, and some may receive medicines such as low-dose chemotherapy or immune therapies if symptoms or complications develop.
Overview
Chronic nk-cell lymphocytosisSymptoms
Chronic NK-cell lymphocytosis often causes no symptoms. When present, early symptoms of chronic NK-cell lymphocytosis include tiredness, frequent infections from low blood counts, and a feeling of fullness from an enlarged spleen; occasional fevers or night sweats can occur.
Outlook and prognosis
Many living with chronic NK-cell lymphocytosis stay stable for years, needing only monitoring. When treatment is needed, it’s often for symptoms like fatigue, infections, or an enlarged spleen, and responses are usually good. Regular follow-up helps catch changes early.
Causes and risk factors
The exact cause of chronic NK-cell lymphocytosis is unclear. Acquired gene changes, immune dysregulation, and past viral exposures may contribute; risk increases with middle to older age. Known risk factors for chronic NK-cell lymphocytosis do not include lifestyle habits.
Genetic influences
Genetics play a modest role in Chronic NK-cell lymphocytosis. Most cases are not inherited, and family clustering is uncommon. Somatic mutations in NK‑cell signaling pathways are sometimes found, influencing disease behavior and guiding targeted therapies or clinical trial options.
Diagnosis
Diagnosis of chronic NK‑cell lymphocytosis is made when repeated blood tests over 6 months show persistently high natural killer (NK) cells. Specialized tests profile NK cells and rule out infection or leukemia; bone marrow or genetic tests may be used.
Treatment and drugs
Treatment for chronic NK-cell lymphocytosis is tailored to symptoms and blood findings. Many do well with watchful monitoring; when treatment’s needed, doctors may use low‑dose immunosuppressants, interferon, or targeted therapies to reduce NK-cell counts and ease complications.
Symptoms
With Chronic NK-cell lymphocytosis, many feel well for a long time, and some changes show up only on a routine blood test. Early symptoms of Chronic NK-cell lymphocytosis can be subtle—fatigue, more frequent infections, or easy bruising that’s hard to explain. Symptoms vary from person to person and can change over time. As blood cell counts shift or the spleen enlarges, everyday tasks may take more effort and infections may linger longer.
Low red blood cells can leave you exhausted, lightheaded, or short of breath with stairs. Rest may help, but the tiredness often returns. Many find daily chores or work take more effort.
In Chronic NK-cell lymphocytosis, low infection-fighting white cells can lead to repeated colds, sinus or chest infections. Cuts and scrapes may take longer to heal. You may notice sore throats or coughs that keep coming back.
Lower platelets mean bruises can appear after minor bumps. You might see nosebleeds, bleeding gums when brushing, or heavier periods. Seek care promptly if bleeding is hard to stop.
Painful ulcers inside the mouth can pop up and heal slowly. They may make eating, drinking, or brushing uncomfortable.
How people usually first notice Chronic nk-cell lymphocytosis?
Many people first notice chronic NK-cell lymphocytosis during a routine blood test that shows a persistent increase in lymphocytes, even though they feel well. If symptoms appear, they’re often mild and nonspecific—such as fatigue, easy bruising, or more frequent colds—which may prompt a doctor to check a complete blood count and then specialized flow cytometry to identify the NK-cell pattern. For many, the “first signs of chronic NK-cell lymphocytosis” are actually lab-based findings rather than clear day-to-day changes.
Types of Chronic nk-cell lymphocytosis
Chronic NK-cell lymphocytosis has a few clinical variants that reflect how active the natural killer (NK) cells are and which markers they carry. These variants can look similar day to day—many people feel well—but blood tests and flow cytometry separate them into clear groups. Symptoms don’t always look the same for everyone. If you’ve been told about different types of chronic NK-cell lymphocytosis, this usually refers to how the cells behave and which surface proteins they show.
CD56dim dominant
This is the most common pattern, with NK cells that focus on cytotoxic activity. People often have stable lymphocyte counts and few or no symptoms. Fatigue or mild infections may occur but are not universal.
CD56bright predominant
This variant features NK cells geared more toward immune signaling than direct killing. Some may notice more autoimmune-type features or low-grade inflammation on labs rather than obvious symptoms. Counts can be steadier, and early symptoms of chronic NK-cell lymphocytosis may be subtle.
KIR-restricted clone
Here, NK cells show a restricted killer immunoglobulin-like receptor (KIR) pattern, suggesting a single expanded clone. Many feel well, but doctors monitor for stability over time. Researchers describe these categories to better understand patterns of the condition.
CD16-negative subset
These NK cells lack CD16, a marker linked to antibody-dependent killing. People may have fewer infection-related symptoms, though this varies. Follow-up focuses on blood counts and the NK-cell profile rather than daily symptoms.
Indolent vs active
Doctors sometimes classify symptoms as indolent versus active. Indolent disease stays quiet with stable counts and minimal symptoms, while a more active course may bring fatigue, night sweats, or recurrent infections. Not everyone will experience every type.
What genetics can tell you about symptoms
Some people with chronic NK-cell lymphocytosis who carry activating KIR gene patterns or STAT3 changes develop more frequent infections, fatigue, and night sweats because the NK cells grow and signal abnormally. Others with less activating KIR combinations may have milder symptoms and slower progression.
Causes and risk factors
The exact cause is unclear, and it seems to develop over time as natural killer white blood cells slowly expand. It may follow long-term immune stimulation, such as after certain viral infections or with autoimmune disease. In some cases, the NK cells carry acquired changes that drive growth, and these changes are not inherited. Risk factors for chronic NK-cell lymphocytosis include older age and immune system disorders, but links to smoking, diet, or exercise are not proven. Having risk factors doesn’t mean you’ll definitely develop the condition.
Environmental and biological risk factors
Chronic NK-cell lymphocytosis happens when a specific type of white blood cell builds up and stays high over time. Some risks are carried inside the body, others come from the world around us. Below are biological and environmental factors that may make this condition more likely. Not everyone with these exposures will ever develop it.
It is most often identified in adults in mid to later life. Age-related shifts in the immune system can let long-lived NK-cell populations persist. Age alone does not determine who develops the condition.
Infections such as cytomegalovirus (CMV) or Epstein–Barr virus (EBV) can drive long-lasting NK-cell stimulation. In some people, that stimulation is followed by an expanded NK-cell population that stays around. This connection does not predict early symptoms of chronic NK-cell lymphocytosis.
Rheumatoid arthritis, autoimmune thyroid disease, or similar conditions may travel alongside this disorder. Ongoing immune activation can increase the likelihood that an NK-cell clone becomes persistent. Many living with autoimmunity never develop it.
Long-standing inflammation from recurring infections or other medical problems can keep the immune system on high alert. This heightened state may favor NK-cell growth over time.
Genetic risk factors
In chronic NK-cell lymphocytosis, genetic changes are usually acquired in blood-forming cells rather than inherited. Carrying a genetic change doesn’t guarantee the condition will appear. Somatic changes often affect a growth pathway called JAK-STAT, with STAT3 and, less often, STAT5B involved. Family risk is generally low, and genetics alone do not predict how the condition will behave.
STAT3 mutations: Activating changes in the STAT3 gene are found in a subset of people with chronic NK-cell lymphocytosis. These changes turn on growth and survival signals that let one NK-cell group expand over time. Genetic results do not reliably predict early symptoms of chronic NK-cell lymphocytosis.
STAT5B mutations: Less common changes in STAT5B can occur in some cases. They affect the same signaling route and may contribute to the slow, chronic build-up of NK cells.
JAK-STAT pathway: Even when no single mutation is detected, tests often show this growth pathway is unusually active. This points to additional, hard-to-capture genetic changes that support NK-cell persistence.
KIR-HLA combinations: Inherited differences in NK-cell receptors (KIR) and their partners on cells (HLA) can favor survival of certain NK-cell clones. These combinations may shape which clones expand but are not enough to cause disease on their own.
Clonal receptor pattern: Many people show a restricted set of KIR on NK cells, a sign one clone has taken the lead. This pattern reflects underlying genetic selection within the NK-cell population rather than a change present in every cell of the body.
Inherited predisposition: Most chronic NK-cell lymphocytosis is not passed down in families. People rarely carry a single inherited mutation that directly causes it.
Lifestyle risk factors
Lifestyle habits can shape symptom burden, infection risk, and overall well‑being in people with this rare lymphoproliferative disorder. While they do not cause the disease, they can influence fatigue, susceptibility to infections, and tolerance of treatments. Below are key lifestyle risk factors for Chronic nk-cell lymphocytosis and how they may affect day‑to‑day health and complications.
Low activity can worsen deconditioning and fatigue that often accompany chronic lymphocyte disorders. Regular moderate movement may improve energy and support immune resilience.
Short or fragmented sleep can dysregulate natural killer cell activity and raise infection susceptibility. A consistent sleep schedule may help stabilize immune function and daytime energy.
Alcohol can suppress NK-cell cytotoxicity and increase the risk of infections or worsen cytopenia-related fatigue. Limiting intake may support immune defenses and treatment tolerance.
Tobacco promotes chronic inflammation and impairs mucosal immunity, raising respiratory infection risk when counts are low. Quitting can reduce complications and cardiovascular strain during illness.
Risk prevention
There’s no proven way to prevent chronic NK-cell lymphocytosis itself, since its exact cause isn’t clear. Prevention in this setting focuses on lowering infection risks, protecting general immune health, and finding any changes early. Prevention works best when combined with regular check-ups. If you’re unsure about early symptoms of chronic NK-cell lymphocytosis, ask your clinician what to watch for and when to get tested.
Periodic complete blood counts can spot persistent NK-cell increases early. Early specialty referral helps confirm the cause and plan follow-up.
Keep influenza, COVID-19, and pneumococcal vaccines current per age and health guidance. This helps lower serious infection risk if your immune system is affected.
Wash hands often, avoid close contact with people who are ill, and follow food and water safety when traveling. Quick care for fevers or unusual infections can prevent complications.
Seek medical attention early for fever, shaking chills, or infections that don’t improve. Early treatment reduces stress on the immune system and lowers hospitalization risk.
Transmission
Chronic NK-cell lymphocytosis is not contagious; you cannot catch it or pass it on through everyday contact, coughing, sex, or shared items. It usually develops later in life because certain natural killer (NK) white blood cells start growing in higher numbers due to changes that happen in those cells over time; these are acquired changes and not the kind that families pass down. There is no clear pattern for how chronic NK-cell lymphocytosis is inherited, and genetic transmission of chronic NK-cell lymphocytosis has not been shown. Children and partners of people with chronic NK-cell lymphocytosis do not have a higher risk just from living together.
When to test your genes
Consider genetic testing if you have persistent elevated NK cells, unexplained symptoms (fatigue, infections), or a family history of blood cancers or immune disorders. Testing is also reasonable before starting targeted therapies, to guide treatment and monitor risks. Discuss timing with a hematologist, who can coordinate appropriate panels and interpret results.
Diagnosis
Early clues often come from routine blood work showing a higher-than-expected lymphocyte count, sometimes before any symptoms appear. Many people feel relief just knowing what’s really going on. Tests may feel repetitive, but each one helps rule out different causes. The diagnosis of Chronic NK-cell lymphocytosis is based on consistent lab patterns over time and confirming that the extra cells are natural killer (NK) cells.
Doctors usually begin by asking about fatigue, infections, autoimmune issues, and any family history. They check for enlarged lymph nodes, liver, or spleen. This helps guide which tests to run first.
A blood test measures white cells and subtypes to confirm lymphocytosis. It also looks for anemia or low neutrophils that can occur alongside Chronic NK-cell lymphocytosis. Results help determine urgency and next steps.
A lab professional reviews the blood under a microscope for large granular lymphocytes. These features support the suspicion of an NK-cell process. The smear also helps rule out other blood disorders.
This test profiles surface markers to confirm the cells are NK cells rather than T or B cells. Typical NK patterns include CD56 and/or CD16 with absence of T-cell markers. This is central to how Chronic NK-cell lymphocytosis is diagnosed at the cellular level.
Stages of Chronic nk-cell lymphocytosis
Chronic nk-cell lymphocytosis does not have defined progression stages. Many people feel relief once they understand what’s happening. This condition often stays stable for years, so doctors focus on tracking symptoms and blood counts rather than assigning stages. Early symptoms of Chronic nk-cell lymphocytosis can be subtle—like mild tiredness or more frequent infections—and diagnosis usually relies on repeat blood tests over time, a careful review of your health and family background, and sometimes specialized lab studies to confirm the cell type.
Outlook and prognosis
Looking ahead can feel daunting, but most people with chronic NK‑cell lymphocytosis live for many years and lead active lives. This condition tends to follow a slow, stable course, especially when the NK cell counts are only mildly to moderately raised. Many people ask, “What does this mean for my future?”, and the short answer is that serious complications are uncommon, though monitoring matters because infections or autoimmune issues can occasionally arise.
Doctors call this the prognosis—a medical word for likely outcomes. For many living with chronic NK‑cell lymphocytosis, there are long stretches without symptoms, and treatment isn’t needed unless problems develop. When symptoms do occur, they’re often mild—fatigue, occasional infections, or enlarged lymph nodes—and early symptoms of chronic NK‑cell lymphocytosis may be subtle enough to miss without routine blood tests. Transformation into an aggressive cancer is rare, and overall survival is generally similar to people without the condition, particularly when other health issues are well managed.
Everyone’s journey looks a little different. Outlook can be influenced by age, other medical conditions, how high the NK‑cell count is, and whether there are autoimmune features or frequent infections. In medical terms, the long-term outlook is often shaped by both genetics and lifestyle, so staying up to date on vaccines, addressing sleep, nutrition, and exercise, and treating other conditions like diabetes or heart disease can help. Talk with your doctor about what your personal outlook might look like, including how often to check blood counts and when to report new symptoms.
Long-term effects
Chronic NK-cell lymphocytosis usually follows a slow, steady course, and many people feel well for years. Long-term effects vary widely, and some never develop symptoms. Doctors often track blood counts and organ size over time to spot changes. Serious complications are uncommon, but a small number develop low blood counts, autoimmune problems, or eventually need treatment.
NK cell levels stay higher than usual over many years. Many living with chronic NK-cell lymphocytosis remain symptom-free despite this.
Some develop low neutrophils, which can raise the risk of infections. This may show up as repeated sinus, chest, or skin infections over time.
Joint pain, thyroid issues, or other autoimmune features can occur alongside chronic NK-cell lymphocytosis. Blood tests may show autoimmune markers even when symptoms are mild.
The spleen can slowly enlarge. You might notice a feeling of fullness under the left ribs or getting full sooner at meals.
How is it to live with Chronic nk-cell lymphocytosis?
Living with chronic NK-cell lymphocytosis often means regular blood tests and check-ins rather than daily symptoms. Many people feel well and continue normal routines, though some notice fatigue, mild infections, or worry about what blood count changes might mean over time. Family and friends may feel concerned at first, but clear information and a stable care plan usually ease that anxiety and help everyone focus on practical support. Day to day, pacing energy, staying current with vaccinations, and keeping a simple record of labs and appointments can make life feel predictable and in control.
Treatment and drugs
Treatment for chronic NK-cell lymphocytosis focuses on monitoring and easing symptoms, since many people do not need immediate therapy. If counts are stable and there are no symptoms, doctors often use active surveillance with regular checkups and blood tests rather than starting medication right away. When treatment is needed—because of troublesome symptoms, anemia, low platelets, or organ involvement—options can include low-dose immune-suppressing medicines such as methotrexate or cyclophosphamide, steroids for short periods, or targeted drugs like cyclosporine; a doctor may adjust your dose to balance benefits and side effects. Infections are managed promptly, and vaccines (non-live) and general infection prevention are important, especially if you’re on immune-suppressing therapy. Supportive care can make a real difference in how you feel day to day, including treating fatigue, managing pain or swelling, and addressing any related autoimmune issues under the guidance of a hematologist.
Non-drug treatment
Many living with chronic NK-cell lymphocytosis do well for years with simple, steady routines that support immunity and energy. Non-drug treatments often lay the foundation for long-term care, even if medicines are added later. Knowing the early symptoms of chronic NK-cell lymphocytosis—like frequent infections, unusual fatigue, or easy bruising—helps you and your care team act sooner.
Regular checkups and blood tests track lymphocyte levels and overall health. Keeping a symptom diary helps spot changes like fevers, night sweats, or new infections early. This approach helps avoid unnecessary treatment while staying safe.
Staying up to date on flu, COVID‑19, and pneumococcal vaccines can lower infection risk. Ask your care team which vaccines fit your situation and timing. Household members staying current adds another layer of protection.
Wash hands often, use alcohol gel when out, and avoid close contact with people who are ill. Seek prompt care for fevers above 38.0°C (100.4°F), shaking chills, or worsening cough. Good dental care and skin care reduce entry points for germs.
Plan your day to balance activity with rest so fatigue doesn’t snowball. Short, frequent breaks and lighter tasks on low‑energy days can help you stay active without overdoing it. Gentle adjustments often prevent setbacks.
Your genes may have an impact on how drugs work for you
Medicines for chronic NK-cell lymphocytosis can work differently based on inherited and tumor-specific gene changes that affect drug targets, metabolism, and immune signaling. Genetic testing can sometimes guide drug choice or dose, aiming for better response with fewer side effects.
Pharmacological treatments
For many living with chronic NK-cell lymphocytosis, treatment focuses on easing infections, fatigue, and low blood counts that get in the way of daily life. If early symptoms of chronic NK-cell lymphocytosis include repeated infections or easy tiredness, medicines are aimed at the blood count problems behind them. First-line medications are those doctors usually try first, based on your symptoms and blood counts. Options often come from low-dose immune-calming drugs, along with supportive medicines to prevent or treat complications.
Taken once weekly to calm the overactive NK-cell clone and improve low blood counts. It may take several weeks to see benefits, with regular checks of liver tests and blood counts.
A low daily dose can be used if methotrexate isn’t effective or tolerated. Doctors often limit the duration due to side effects like low blood counts and bladder irritation.
Helps curb immune overactivity when anemia or low white cells persist. Blood pressure, kidney function, and drug interactions need close monitoring.
Short courses can quickly improve severe fatigue or very low counts. Long-term use is avoided because of side effects like weight gain, high blood sugar, and bone thinning.
Genetic influences
Most cases seem to arise from changes that NK cells pick up over time, rather than from genes you were born with. People often ask whether chronic NK-cell lymphocytosis is hereditary; in most cases, it is not, and it usually doesn’t run in families. Genetics is only one piece of the puzzle, but doctors sometimes find acquired gene changes inside the NK cells that act like stuck “on” switches, helping these cells live longer and build up in the blood.
Because these changes occur in the blood cells themselves, they typically aren’t passed to children. When needed, genetic testing for chronic NK-cell lymphocytosis looks for these cell changes to support the diagnosis or help guide care, but routine family (germline) testing isn’t usually helpful. Even when a gene change is found in the NK cells, risk for relatives remains low, and other factors—such as immune system triggers and age—likely play a role.
Is Chronic nk-cell lymphocytosis genetic?
Genetics play a modest role in Chronic NK-cell lymphocytosis. Most cases are not inherited, and family clustering is uncommon. Somatic mutations in NK‑cell signaling pathways are sometimes found, influencing disease behavior and guiding targeted therapies or clinical trial options.
Pharmacogenetics—how genetics influence drug effects
In Chronic NK-cell lymphocytosis, genetics matter in two ways: the genes within the NK cells can shape the illness, and your own genes can affect how you handle medicines used to treat it. Some people have changes in the JAK–STAT pathway (medically, mutations in STAT3 or STAT5B), which helps confirm the diagnosis and may guide doctors toward targeted options being studied, while most care still relies on watchful waiting or low‑dose immunosuppressants. You don’t choose how your body processes medicine, but your care team can use blood tests and your feedback to fine‑tune drugs like methotrexate, cyclophosphamide, or cyclosporine to balance benefit and side effects. Differences in drug‑processing genes can influence how quickly you clear these medicines and your risk of liver irritation, low blood counts, or other reactions; however, routine pharmacogenetic testing isn’t standard yet, so dosing is usually adjusted based on monitoring. When targeted therapy such as a JAK inhibitor is considered, tumor genetic results help judge whether it’s reasonable for your situation, alongside your overall health and other medications. In short, genetics informs treatment choices for Chronic NK-cell lymphocytosis, but day‑to‑day decisions still lean on clinical features, regular lab checks, and how you feel on therapy.
Interactions with other conditions
Day to day, symptoms from chronic NK-cell lymphocytosis can blend with those from other health issues, which makes fatigue, infections, or joint aches harder to sort out. Doctors call it a “comorbidity” when two conditions occur together. Chronic NK-cell lymphocytosis sometimes overlaps with autoimmune conditions, and when it causes low neutrophils (a type of white cell), common infections—like sinus, chest, or skin infections—may happen more often or hit harder. Treatments used for autoimmune disease, such as immune‑calming medicines, can occasionally ease blood count problems from chronic NK-cell lymphocytosis, but they may also increase infection risk, so plans usually need to be coordinated across specialists.
Viral illnesses or significant stress on the body can temporarily worsen blood counts, which may make symptoms flare. For some, early symptoms of chronic NK-cell lymphocytosis—such as tiredness or repeated infections—are shaped more by an overlapping condition than by the lymphocytosis itself. Interactions can look very different from person to person, so your care team will factor in all diagnoses, medicines, and vaccination needs when tailoring your treatment. If you live with another long-term condition, let your clinicians know about any new fevers, bruising, or infection signs promptly, as small changes can matter when conditions overlap.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Families and communities once noticed patterns of lingering fatigue, easy bruising, or frequent infections in certain relatives, even when life went on mostly as usual. Doctors examining these stories sometimes found a quiet, steady rise in a specific type of white blood cell. Decades before modern blood tests were common, this slow, symptom-light picture rarely drew attention, so many lived with it unnoticed.
First described in the medical literature as a persistent increase in natural killer (NK) lymphocytes, chronic NK-cell lymphocytosis came into focus as routine complete blood counts became widespread in the late 20th century. Clinicians began seeing people who felt well but had a stable, higher-than-expected NK-cell count on repeated tests. Initially understood only through symptoms, later definitions centered on blood features—how high the NK-cell count stayed, how long it persisted, and whether cells showed certain markers on their surface.
From early theories to modern research, the story of chronic NK-cell lymphocytosis reflects how laboratory tools shape our understanding. Flow cytometry, which tags cells by their surface proteins, helped separate this condition from look-alikes such as chronic viral reactions or other lymphocyte disorders. Over time, descriptions became more consistent: a chronic, usually indolent increase in NK cells without the organ swelling, weight loss, or night sweats that mark more aggressive illnesses.
In recent decades, knowledge has built on a long tradition of observation. Researchers connected clinical clues—like stable blood counts over months—to subtle immune patterns. Many living with chronic NK-cell lymphocytosis had no symptoms at all, while some experienced mild fatigue or repeated minor infections. This variability led to careful follow-up strategies rather than immediate treatment, emphasizing watchful waiting and regular monitoring.
Advances in genetics refined the picture but did not rewrite it. Studies identified recurring immune-signaling changes in some cases, helping explain why NK cells expand in a steady, controlled way rather than turning into fast-growing cancer. At the same time, the absence of widespread organ damage or rapidly rising counts kept chronic NK-cell lymphocytosis grouped with other slow, chronic lymphoproliferative disorders rather than aggressive blood cancers.
Once considered rare, now recognized as more common thanks to routine blood work, chronic NK-cell lymphocytosis remains a condition defined as much by pace as by presence. Knowing the condition’s history helps explain today’s approach: confirm the pattern, look for triggers or mimics, and prioritize long-term observation. Each stage in history has added to the picture we have today—a clearer understanding that for many, this is a stable, manageable finding that merits attention but not alarm.